ResMed Inc. (RMD) has a market capitalization of $33.67B and trades at $230.69. The 52-week range is 199.92-293.81.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 24.2, Earnings Per Share (EPS) of $9.55, annual revenue of $5.15B.
The stock has a beta of 0.93, a last dividend of $2.3300, operates in the Healthcare sector.
